Dr. Kenneth J. Cohen
Claim this profileJohns Hopkins University/Sidney Kimmel Cancer Center
Expert in Brain Tumor
Expert in Recurrence
49 reported clinical trials
94 drugs studied
Area of expertise
1Brain Tumor
Global LeaderStage I
Stage II
Stage IV
2Recurrence
Global LeaderStage I
Stage II
IDH positive
Affiliated Hospitals
Clinical Trials Kenneth J. Cohen is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
More about Kenneth J. Cohen
Clinical Trial Related7 years of experience running clinical trials · Led 49 trials as a Principal Investigator · 23 Active Clinical TrialsTreatments Kenneth J. Cohen has experience with
- Radiation Therapy
- Cyclophosphamide
- Temozolomide
- Methotrexate
- Pegaspargase
- Dexamethasone
Breakdown of trials Kenneth J. Cohen has run
Brain Tumor
Recurrence
Glioblastoma
Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kenneth J. Cohen specialize in?
Kenneth J. Cohen focuses on Brain Tumor and Recurrence. In particular, much of their work with Brain Tumor has involved Stage I patients, or patients who are Stage II.
Is Kenneth J. Cohen currently recruiting for clinical trials?
Yes, Kenneth J. Cohen is currently recruiting for 20 clinical trials in Baltimore Maryland. If you're interested in participating, you should apply.
Are there any treatments that Kenneth J. Cohen has studied deeply?
Yes, Kenneth J. Cohen has studied treatments such as Radiation Therapy, Cyclophosphamide, Temozolomide.
What is the best way to schedule an appointment with Kenneth J. Cohen?
Apply for one of the trials that Kenneth J. Cohen is conducting.
What is the office address of Kenneth J. Cohen?
The office of Kenneth J. Cohen is located at: Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland 21287 United States. This is the address for their practice at the Johns Hopkins University/Sidney Kimmel Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.